nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoprolol—ABCB1—colon cancer	0.782	1	CbGaD
Metoprolol—Chlorphenesin—PTGS2—colon cancer	0.00102	0.337	CrCbGaD
Metoprolol—Atenolol—ABCB1—colon cancer	0.000869	0.286	CrCbGaD
Metoprolol—Acebutolol—ABCB1—colon cancer	0.000802	0.264	CrCbGaD
Metoprolol—Disturbance in sexual arousal—Capecitabine—colon cancer	0.00074	0.00344	CcSEcCtD
Metoprolol—Depressed level of consciousness—Methotrexate—colon cancer	0.000738	0.00343	CcSEcCtD
Metoprolol—Cardiac disorder—Vincristine—colon cancer	0.000734	0.00342	CcSEcCtD
Metoprolol—Angiopathy—Vincristine—colon cancer	0.000718	0.00334	CcSEcCtD
Metoprolol—Cardiac disorder—Irinotecan—colon cancer	0.000715	0.00333	CcSEcCtD
Metoprolol—Mediastinal disorder—Vincristine—colon cancer	0.000713	0.00332	CcSEcCtD
Metoprolol—Cardiac arrest—Capecitabine—colon cancer	0.000709	0.0033	CcSEcCtD
Metoprolol—Mood swings—Capecitabine—colon cancer	0.000706	0.00329	CcSEcCtD
Metoprolol—Alopecia—Vincristine—colon cancer	0.000699	0.00325	CcSEcCtD
Metoprolol—Angiopathy—Irinotecan—colon cancer	0.000699	0.00325	CcSEcCtD
Metoprolol—Coma—Methotrexate—colon cancer	0.000699	0.00325	CcSEcCtD
Metoprolol—Immune system disorder—Irinotecan—colon cancer	0.000696	0.00324	CcSEcCtD
Metoprolol—Mediastinal disorder—Irinotecan—colon cancer	0.000695	0.00323	CcSEcCtD
Metoprolol—Mental disorder—Vincristine—colon cancer	0.000693	0.00323	CcSEcCtD
Metoprolol—Arrhythmia—Irinotecan—colon cancer	0.000689	0.0032	CcSEcCtD
Metoprolol—Liver function test abnormal—Capecitabine—colon cancer	0.000688	0.0032	CcSEcCtD
Metoprolol—Alopecia—Irinotecan—colon cancer	0.000681	0.00317	CcSEcCtD
Metoprolol—Abdominal pain upper—Capecitabine—colon cancer	0.000681	0.00317	CcSEcCtD
Metoprolol—Orthostatic hypotension—Capecitabine—colon cancer	0.000681	0.00317	CcSEcCtD
Metoprolol—Breast disorder—Capecitabine—colon cancer	0.000674	0.00313	CcSEcCtD
Metoprolol—Flatulence—Irinotecan—colon cancer	0.000661	0.00308	CcSEcCtD
Metoprolol—Arrhythmia—Fluorouracil—colon cancer	0.000659	0.00307	CcSEcCtD
Metoprolol—Alopecia—Fluorouracil—colon cancer	0.000652	0.00303	CcSEcCtD
Metoprolol—Muscle spasms—Irinotecan—colon cancer	0.000645	0.003	CcSEcCtD
Metoprolol—Diabetes mellitus—Methotrexate—colon cancer	0.000638	0.00297	CcSEcCtD
Metoprolol—Bronchospasm—Capecitabine—colon cancer	0.000634	0.00295	CcSEcCtD
Metoprolol—Photosensitivity—Methotrexate—colon cancer	0.000632	0.00294	CcSEcCtD
Metoprolol—Sweating increased—Capecitabine—colon cancer	0.000628	0.00292	CcSEcCtD
Metoprolol—Angina pectoris—Capecitabine—colon cancer	0.000628	0.00292	CcSEcCtD
Metoprolol—Vertigo—Vincristine—colon cancer	0.000619	0.00288	CcSEcCtD
Metoprolol—Leukopenia—Vincristine—colon cancer	0.000617	0.00287	CcSEcCtD
Metoprolol—Vision blurred—Fluorouracil—colon cancer	0.000606	0.00282	CcSEcCtD
Metoprolol—Vertigo—Irinotecan—colon cancer	0.000603	0.0028	CcSEcCtD
Metoprolol—Syncope—Irinotecan—colon cancer	0.000602	0.0028	CcSEcCtD
Metoprolol—Leukopenia—Irinotecan—colon cancer	0.000601	0.00279	CcSEcCtD
Metoprolol—Hypertension—Vincristine—colon cancer	0.000595	0.00277	CcSEcCtD
Metoprolol—Loss of consciousness—Irinotecan—colon cancer	0.00059	0.00274	CcSEcCtD
Metoprolol—Photosensitivity reaction—Capecitabine—colon cancer	0.000588	0.00274	CcSEcCtD
Metoprolol—Weight increased—Capecitabine—colon cancer	0.000587	0.00273	CcSEcCtD
Metoprolol—Visual disturbance—Methotrexate—colon cancer	0.000586	0.00272	CcSEcCtD
Metoprolol—Hypertension—Irinotecan—colon cancer	0.000579	0.00269	CcSEcCtD
Metoprolol—Pneumonia—Capecitabine—colon cancer	0.000578	0.00269	CcSEcCtD
Metoprolol—Leukopenia—Fluorouracil—colon cancer	0.000575	0.00268	CcSEcCtD
Metoprolol—Depression—Capecitabine—colon cancer	0.000573	0.00267	CcSEcCtD
Metoprolol—Cerebrovascular accident—Methotrexate—colon cancer	0.000566	0.00263	CcSEcCtD
Metoprolol—Oedema—Vincristine—colon cancer	0.000562	0.00262	CcSEcCtD
Metoprolol—Jaundice—Capecitabine—colon cancer	0.00056	0.00261	CcSEcCtD
Metoprolol—Conjunctivitis—Capecitabine—colon cancer	0.000559	0.0026	CcSEcCtD
Metoprolol—Confusional state—Irinotecan—colon cancer	0.000552	0.00257	CcSEcCtD
Metoprolol—Nervous system disorder—Vincristine—colon cancer	0.000551	0.00256	CcSEcCtD
Metoprolol—Thrombocytopenia—Vincristine—colon cancer	0.000551	0.00256	CcSEcCtD
Metoprolol—Oedema—Irinotecan—colon cancer	0.000548	0.00255	CcSEcCtD
Metoprolol—Chest pain—Fluorouracil—colon cancer	0.000547	0.00254	CcSEcCtD
Metoprolol—Hyperhidrosis—Vincristine—colon cancer	0.000544	0.00253	CcSEcCtD
Metoprolol—Hepatobiliary disease—Capecitabine—colon cancer	0.000543	0.00253	CcSEcCtD
Metoprolol—Shock—Irinotecan—colon cancer	0.000539	0.00251	CcSEcCtD
Metoprolol—Nervous system disorder—Irinotecan—colon cancer	0.000537	0.0025	CcSEcCtD
Metoprolol—Agranulocytosis—Capecitabine—colon cancer	0.000536	0.00249	CcSEcCtD
Metoprolol—Thrombocytopenia—Irinotecan—colon cancer	0.000536	0.00249	CcSEcCtD
Metoprolol—Hyperhidrosis—Irinotecan—colon cancer	0.000529	0.00246	CcSEcCtD
Metoprolol—Confusional state—Fluorouracil—colon cancer	0.000529	0.00246	CcSEcCtD
Metoprolol—Mood swings—Methotrexate—colon cancer	0.000526	0.00245	CcSEcCtD
Metoprolol—Hypotension—Vincristine—colon cancer	0.000525	0.00244	CcSEcCtD
Metoprolol—Bradycardia—Capecitabine—colon cancer	0.000525	0.00244	CcSEcCtD
Metoprolol—Oedema—Fluorouracil—colon cancer	0.000524	0.00244	CcSEcCtD
Metoprolol—Rhinitis—Capecitabine—colon cancer	0.000517	0.00241	CcSEcCtD
Metoprolol—Hepatitis—Capecitabine—colon cancer	0.000516	0.0024	CcSEcCtD
Metoprolol—Nervous system disorder—Fluorouracil—colon cancer	0.000514	0.00239	CcSEcCtD
Metoprolol—Thrombocytopenia—Fluorouracil—colon cancer	0.000513	0.00239	CcSEcCtD
Metoprolol—Liver function test abnormal—Methotrexate—colon cancer	0.000512	0.00238	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Vincristine—colon cancer	0.000512	0.00238	CcSEcCtD
Metoprolol—Tachycardia—Fluorouracil—colon cancer	0.000512	0.00238	CcSEcCtD
Metoprolol—Hypotension—Irinotecan—colon cancer	0.000512	0.00238	CcSEcCtD
Metoprolol—Insomnia—Vincristine—colon cancer	0.000509	0.00237	CcSEcCtD
Metoprolol—Oedema peripheral—Capecitabine—colon cancer	0.000508	0.00236	CcSEcCtD
Metoprolol—Connective tissue disorder—Capecitabine—colon cancer	0.000507	0.00236	CcSEcCtD
Metoprolol—Paraesthesia—Vincristine—colon cancer	0.000505	0.00235	CcSEcCtD
Metoprolol—Breast disorder—Methotrexate—colon cancer	0.000502	0.00233	CcSEcCtD
Metoprolol—Visual impairment—Capecitabine—colon cancer	0.000497	0.00231	CcSEcCtD
Metoprolol—Insomnia—Irinotecan—colon cancer	0.000495	0.0023	CcSEcCtD
Metoprolol—Paraesthesia—Irinotecan—colon cancer	0.000492	0.00229	CcSEcCtD
Metoprolol—Hypotension—Fluorouracil—colon cancer	0.00049	0.00228	CcSEcCtD
Metoprolol—Dyspnoea—Irinotecan—colon cancer	0.000488	0.00227	CcSEcCtD
Metoprolol—Somnolence—Irinotecan—colon cancer	0.000487	0.00226	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Vincristine—colon cancer	0.000485	0.00226	CcSEcCtD
Metoprolol—Fatigue—Vincristine—colon cancer	0.000485	0.00225	CcSEcCtD
Metoprolol—Eye disorder—Capecitabine—colon cancer	0.000482	0.00224	CcSEcCtD
Metoprolol—Dyspepsia—Irinotecan—colon cancer	0.000482	0.00224	CcSEcCtD
Metoprolol—Tinnitus—Capecitabine—colon cancer	0.000481	0.00224	CcSEcCtD
Metoprolol—Pain—Vincristine—colon cancer	0.000481	0.00224	CcSEcCtD
Metoprolol—Constipation—Vincristine—colon cancer	0.000481	0.00224	CcSEcCtD
Metoprolol—Cardiac disorder—Capecitabine—colon cancer	0.000479	0.00223	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000478	0.00222	CcSEcCtD
Metoprolol—Insomnia—Fluorouracil—colon cancer	0.000474	0.00221	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Irinotecan—colon cancer	0.000473	0.0022	CcSEcCtD
Metoprolol—Fatigue—Irinotecan—colon cancer	0.000472	0.0022	CcSEcCtD
Metoprolol—Paraesthesia—Fluorouracil—colon cancer	0.000471	0.00219	CcSEcCtD
Metoprolol—Pain—Irinotecan—colon cancer	0.000468	0.00218	CcSEcCtD
Metoprolol—Constipation—Irinotecan—colon cancer	0.000468	0.00218	CcSEcCtD
Metoprolol—Angiopathy—Capecitabine—colon cancer	0.000468	0.00218	CcSEcCtD
Metoprolol—Dyspnoea—Fluorouracil—colon cancer	0.000468	0.00217	CcSEcCtD
Metoprolol—Somnolence—Fluorouracil—colon cancer	0.000466	0.00217	CcSEcCtD
Metoprolol—Immune system disorder—Capecitabine—colon cancer	0.000466	0.00217	CcSEcCtD
Metoprolol—Mediastinal disorder—Capecitabine—colon cancer	0.000465	0.00216	CcSEcCtD
Metoprolol—Dyspepsia—Fluorouracil—colon cancer	0.000462	0.00215	CcSEcCtD
Metoprolol—Arrhythmia—Capecitabine—colon cancer	0.000461	0.00214	CcSEcCtD
Metoprolol—Gastrointestinal pain—Vincristine—colon cancer	0.00046	0.00214	CcSEcCtD
Metoprolol—Alopecia—Capecitabine—colon cancer	0.000456	0.00212	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000453	0.00211	CcSEcCtD
Metoprolol—Mental disorder—Capecitabine—colon cancer	0.000452	0.0021	CcSEcCtD
Metoprolol—Feeling abnormal—Irinotecan—colon cancer	0.000451	0.0021	CcSEcCtD
Metoprolol—Pain—Fluorouracil—colon cancer	0.000448	0.00209	CcSEcCtD
Metoprolol—Gastrointestinal pain—Irinotecan—colon cancer	0.000448	0.00208	CcSEcCtD
Metoprolol—Body temperature increased—Vincristine—colon cancer	0.000444	0.00207	CcSEcCtD
Metoprolol—Abdominal pain—Vincristine—colon cancer	0.000444	0.00207	CcSEcCtD
Metoprolol—Flatulence—Capecitabine—colon cancer	0.000442	0.00206	CcSEcCtD
Metoprolol—Erectile dysfunction—Methotrexate—colon cancer	0.000442	0.00206	CcSEcCtD
Metoprolol—Dysgeusia—Capecitabine—colon cancer	0.00044	0.00205	CcSEcCtD
Metoprolol—Photosensitivity reaction—Methotrexate—colon cancer	0.000438	0.00204	CcSEcCtD
Metoprolol—Abdominal pain—Irinotecan—colon cancer	0.000433	0.00201	CcSEcCtD
Metoprolol—Body temperature increased—Irinotecan—colon cancer	0.000433	0.00201	CcSEcCtD
Metoprolol—Feeling abnormal—Fluorouracil—colon cancer	0.000432	0.00201	CcSEcCtD
Metoprolol—Muscle spasms—Capecitabine—colon cancer	0.000432	0.00201	CcSEcCtD
Metoprolol—Pneumonia—Methotrexate—colon cancer	0.00043	0.002	CcSEcCtD
Metoprolol—Depression—Methotrexate—colon cancer	0.000427	0.00198	CcSEcCtD
Metoprolol—Vision blurred—Capecitabine—colon cancer	0.000423	0.00197	CcSEcCtD
Metoprolol—Urticaria—Fluorouracil—colon cancer	0.000417	0.00194	CcSEcCtD
Metoprolol—Conjunctivitis—Methotrexate—colon cancer	0.000416	0.00193	CcSEcCtD
Metoprolol—Body temperature increased—Fluorouracil—colon cancer	0.000415	0.00193	CcSEcCtD
Metoprolol—Hypersensitivity—Vincristine—colon cancer	0.000414	0.00193	CcSEcCtD
Metoprolol—Sweating—Methotrexate—colon cancer	0.00041	0.00191	CcSEcCtD
Metoprolol—Hepatobiliary disease—Methotrexate—colon cancer	0.000405	0.00188	CcSEcCtD
Metoprolol—Vertigo—Capecitabine—colon cancer	0.000403	0.00188	CcSEcCtD
Metoprolol—Hypersensitivity—Irinotecan—colon cancer	0.000403	0.00188	CcSEcCtD
Metoprolol—Asthenia—Vincristine—colon cancer	0.000403	0.00188	CcSEcCtD
Metoprolol—Syncope—Capecitabine—colon cancer	0.000403	0.00187	CcSEcCtD
Metoprolol—Leukopenia—Capecitabine—colon cancer	0.000402	0.00187	CcSEcCtD
Metoprolol—Agranulocytosis—Methotrexate—colon cancer	0.000399	0.00186	CcSEcCtD
Metoprolol—Palpitations—Capecitabine—colon cancer	0.000397	0.00185	CcSEcCtD
Metoprolol—Loss of consciousness—Capecitabine—colon cancer	0.000395	0.00184	CcSEcCtD
Metoprolol—Asthenia—Irinotecan—colon cancer	0.000393	0.00183	CcSEcCtD
Metoprolol—Hypertension—Capecitabine—colon cancer	0.000388	0.0018	CcSEcCtD
Metoprolol—Hypersensitivity—Fluorouracil—colon cancer	0.000386	0.0018	CcSEcCtD
Metoprolol—Diarrhoea—Vincristine—colon cancer	0.000385	0.00179	CcSEcCtD
Metoprolol—Hepatitis—Methotrexate—colon cancer	0.000384	0.00179	CcSEcCtD
Metoprolol—Arthralgia—Capecitabine—colon cancer	0.000382	0.00178	CcSEcCtD
Metoprolol—Chest pain—Capecitabine—colon cancer	0.000382	0.00178	CcSEcCtD
Metoprolol—Anxiety—Capecitabine—colon cancer	0.000381	0.00177	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00038	0.00177	CcSEcCtD
Metoprolol—Diarrhoea—Irinotecan—colon cancer	0.000375	0.00174	CcSEcCtD
Metoprolol—Dry mouth—Capecitabine—colon cancer	0.000374	0.00174	CcSEcCtD
Metoprolol—Dizziness—Vincristine—colon cancer	0.000372	0.00173	CcSEcCtD
Metoprolol—Pruritus—Fluorouracil—colon cancer	0.000371	0.00173	CcSEcCtD
Metoprolol—Visual impairment—Methotrexate—colon cancer	0.00037	0.00172	CcSEcCtD
Metoprolol—Confusional state—Capecitabine—colon cancer	0.00037	0.00172	CcSEcCtD
Metoprolol—Oedema—Capecitabine—colon cancer	0.000366	0.0017	CcSEcCtD
Metoprolol—Dizziness—Irinotecan—colon cancer	0.000362	0.00168	CcSEcCtD
Metoprolol—Shock—Capecitabine—colon cancer	0.000361	0.00168	CcSEcCtD
Metoprolol—Nervous system disorder—Capecitabine—colon cancer	0.000359	0.00167	CcSEcCtD
Metoprolol—Eye disorder—Methotrexate—colon cancer	0.000359	0.00167	CcSEcCtD
Metoprolol—Diarrhoea—Fluorouracil—colon cancer	0.000359	0.00167	CcSEcCtD
Metoprolol—Thrombocytopenia—Capecitabine—colon cancer	0.000359	0.00167	CcSEcCtD
Metoprolol—Tinnitus—Methotrexate—colon cancer	0.000358	0.00167	CcSEcCtD
Metoprolol—Tachycardia—Capecitabine—colon cancer	0.000358	0.00166	CcSEcCtD
Metoprolol—Vomiting—Vincristine—colon cancer	0.000357	0.00166	CcSEcCtD
Metoprolol—Cardiac disorder—Methotrexate—colon cancer	0.000356	0.00166	CcSEcCtD
Metoprolol—Skin disorder—Capecitabine—colon cancer	0.000356	0.00166	CcSEcCtD
Metoprolol—Rash—Vincristine—colon cancer	0.000355	0.00165	CcSEcCtD
Metoprolol—Hyperhidrosis—Capecitabine—colon cancer	0.000354	0.00165	CcSEcCtD
Metoprolol—Dermatitis—Vincristine—colon cancer	0.000354	0.00165	CcSEcCtD
Metoprolol—Headache—Vincristine—colon cancer	0.000352	0.00164	CcSEcCtD
Metoprolol—Angiopathy—Methotrexate—colon cancer	0.000348	0.00162	CcSEcCtD
Metoprolol—Vomiting—Irinotecan—colon cancer	0.000348	0.00162	CcSEcCtD
Metoprolol—Immune system disorder—Methotrexate—colon cancer	0.000347	0.00161	CcSEcCtD
Metoprolol—Dizziness—Fluorouracil—colon cancer	0.000347	0.00161	CcSEcCtD
Metoprolol—Mediastinal disorder—Methotrexate—colon cancer	0.000346	0.00161	CcSEcCtD
Metoprolol—Rash—Irinotecan—colon cancer	0.000345	0.00161	CcSEcCtD
Metoprolol—Dermatitis—Irinotecan—colon cancer	0.000345	0.0016	CcSEcCtD
Metoprolol—Headache—Irinotecan—colon cancer	0.000343	0.0016	CcSEcCtD
Metoprolol—Hypotension—Capecitabine—colon cancer	0.000342	0.00159	CcSEcCtD
Metoprolol—Propranolol—ABCB1—colon cancer	0.000342	0.113	CrCbGaD
Metoprolol—Alopecia—Methotrexate—colon cancer	0.000339	0.00158	CcSEcCtD
Metoprolol—Mental disorder—Methotrexate—colon cancer	0.000336	0.00156	CcSEcCtD
Metoprolol—Nausea—Vincristine—colon cancer	0.000334	0.00155	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000334	0.00155	CcSEcCtD
Metoprolol—Vomiting—Fluorouracil—colon cancer	0.000333	0.00155	CcSEcCtD
Metoprolol—Insomnia—Capecitabine—colon cancer	0.000331	0.00154	CcSEcCtD
Metoprolol—Rash—Fluorouracil—colon cancer	0.000331	0.00154	CcSEcCtD
Metoprolol—Dermatitis—Fluorouracil—colon cancer	0.00033	0.00154	CcSEcCtD
Metoprolol—Paraesthesia—Capecitabine—colon cancer	0.000329	0.00153	CcSEcCtD
Metoprolol—Headache—Fluorouracil—colon cancer	0.000329	0.00153	CcSEcCtD
Metoprolol—Dysgeusia—Methotrexate—colon cancer	0.000327	0.00152	CcSEcCtD
Metoprolol—Dyspnoea—Capecitabine—colon cancer	0.000327	0.00152	CcSEcCtD
Metoprolol—Nausea—Irinotecan—colon cancer	0.000325	0.00151	CcSEcCtD
Metoprolol—Dyspepsia—Capecitabine—colon cancer	0.000323	0.0015	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Capecitabine—colon cancer	0.000316	0.00147	CcSEcCtD
Metoprolol—Fatigue—Capecitabine—colon cancer	0.000316	0.00147	CcSEcCtD
Metoprolol—Vision blurred—Methotrexate—colon cancer	0.000315	0.00147	CcSEcCtD
Metoprolol—Pain—Capecitabine—colon cancer	0.000313	0.00146	CcSEcCtD
Metoprolol—Constipation—Capecitabine—colon cancer	0.000313	0.00146	CcSEcCtD
Metoprolol—Nausea—Fluorouracil—colon cancer	0.000312	0.00145	CcSEcCtD
Metoprolol—Feeling abnormal—Capecitabine—colon cancer	0.000302	0.0014	CcSEcCtD
Metoprolol—Vertigo—Methotrexate—colon cancer	0.0003	0.0014	CcSEcCtD
Metoprolol—Gastrointestinal pain—Capecitabine—colon cancer	0.0003	0.00139	CcSEcCtD
Metoprolol—Leukopenia—Methotrexate—colon cancer	0.000299	0.00139	CcSEcCtD
Metoprolol—Urticaria—Capecitabine—colon cancer	0.000291	0.00135	CcSEcCtD
Metoprolol—Body temperature increased—Capecitabine—colon cancer	0.00029	0.00135	CcSEcCtD
Metoprolol—Abdominal pain—Capecitabine—colon cancer	0.00029	0.00135	CcSEcCtD
Metoprolol—Arthralgia—Methotrexate—colon cancer	0.000285	0.00132	CcSEcCtD
Metoprolol—Chest pain—Methotrexate—colon cancer	0.000285	0.00132	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000283	0.00131	CcSEcCtD
Metoprolol—Confusional state—Methotrexate—colon cancer	0.000275	0.00128	CcSEcCtD
Metoprolol—Hypersensitivity—Capecitabine—colon cancer	0.00027	0.00126	CcSEcCtD
Metoprolol—Nervous system disorder—Methotrexate—colon cancer	0.000268	0.00124	CcSEcCtD
Metoprolol—Thrombocytopenia—Methotrexate—colon cancer	0.000267	0.00124	CcSEcCtD
Metoprolol—Skin disorder—Methotrexate—colon cancer	0.000265	0.00123	CcSEcCtD
Metoprolol—Hyperhidrosis—Methotrexate—colon cancer	0.000264	0.00123	CcSEcCtD
Metoprolol—Asthenia—Capecitabine—colon cancer	0.000263	0.00122	CcSEcCtD
Metoprolol—Pruritus—Capecitabine—colon cancer	0.000259	0.00121	CcSEcCtD
Metoprolol—Hypotension—Methotrexate—colon cancer	0.000255	0.00119	CcSEcCtD
Metoprolol—Diarrhoea—Capecitabine—colon cancer	0.000251	0.00117	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000249	0.00116	CcSEcCtD
Metoprolol—Insomnia—Methotrexate—colon cancer	0.000247	0.00115	CcSEcCtD
Metoprolol—Paraesthesia—Methotrexate—colon cancer	0.000245	0.00114	CcSEcCtD
Metoprolol—Dyspnoea—Methotrexate—colon cancer	0.000243	0.00113	CcSEcCtD
Metoprolol—Somnolence—Methotrexate—colon cancer	0.000243	0.00113	CcSEcCtD
Metoprolol—Dizziness—Capecitabine—colon cancer	0.000242	0.00113	CcSEcCtD
Metoprolol—Dyspepsia—Methotrexate—colon cancer	0.00024	0.00112	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Methotrexate—colon cancer	0.000236	0.0011	CcSEcCtD
Metoprolol—Fatigue—Methotrexate—colon cancer	0.000235	0.00109	CcSEcCtD
Metoprolol—Pain—Methotrexate—colon cancer	0.000233	0.00109	CcSEcCtD
Metoprolol—Vomiting—Capecitabine—colon cancer	0.000233	0.00108	CcSEcCtD
Metoprolol—Rash—Capecitabine—colon cancer	0.000231	0.00107	CcSEcCtD
Metoprolol—Dermatitis—Capecitabine—colon cancer	0.000231	0.00107	CcSEcCtD
Metoprolol—Headache—Capecitabine—colon cancer	0.00023	0.00107	CcSEcCtD
Metoprolol—Feeling abnormal—Methotrexate—colon cancer	0.000225	0.00105	CcSEcCtD
Metoprolol—Gastrointestinal pain—Methotrexate—colon cancer	0.000223	0.00104	CcSEcCtD
Metoprolol—Nausea—Capecitabine—colon cancer	0.000218	0.00101	CcSEcCtD
Metoprolol—Urticaria—Methotrexate—colon cancer	0.000217	0.00101	CcSEcCtD
Metoprolol—Abdominal pain—Methotrexate—colon cancer	0.000216	0.001	CcSEcCtD
Metoprolol—Body temperature increased—Methotrexate—colon cancer	0.000216	0.001	CcSEcCtD
Metoprolol—Hypersensitivity—Methotrexate—colon cancer	0.000201	0.000935	CcSEcCtD
Metoprolol—Asthenia—Methotrexate—colon cancer	0.000196	0.000911	CcSEcCtD
Metoprolol—Pruritus—Methotrexate—colon cancer	0.000193	0.000898	CcSEcCtD
Metoprolol—Diarrhoea—Methotrexate—colon cancer	0.000187	0.000868	CcSEcCtD
Metoprolol—Dizziness—Methotrexate—colon cancer	0.00018	0.000839	CcSEcCtD
Metoprolol—Vomiting—Methotrexate—colon cancer	0.000173	0.000807	CcSEcCtD
Metoprolol—Rash—Methotrexate—colon cancer	0.000172	0.0008	CcSEcCtD
Metoprolol—Dermatitis—Methotrexate—colon cancer	0.000172	0.000799	CcSEcCtD
Metoprolol—Headache—Methotrexate—colon cancer	0.000171	0.000795	CcSEcCtD
Metoprolol—Nausea—Methotrexate—colon cancer	0.000162	0.000754	CcSEcCtD
